The Second Canadian Symposium on Hepatitis C Virus: A call to action

In Canada, hepatitis C virus (HCV) infection results in considerable morbidity, mortality and health-related costs. Within the next three to 10 years, it is expected that tolerable, short-duration (12 to 24 weeks) therapies capable of curing >90% of those who undergo treatment will be approved. G...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Grebely, Jason, Bilodeau, Marc, Feld, Jordan J, Bruneau, Julie, Fischer, Benedikt, Raven, Jennifer F, Roberts, Eve, Choucha, Norma, Myers, Rob P, Sagan, Selena M, Wilson, Joyce A, Bialystok, Frank, Tyrrell, D Lorne, Houghton, Michael, Krajden, Mel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pulsus Group Inc 2013
Soggetti:
Commentary
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816942/
https://ncbi.nlm.nih.gov/pubmed/24199209
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi